TrialJournal of clinical pharmacology2017

Pharmacokinetic, Pharmacodynamic, and Safety Profile of a Novel Anti-CD28 Domain Antibody Antagonist in Healthy Subjects.

Rong Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.